tiprankstipranks
Tissue Regenix Issues New Shares Post-Options Exercise
Company Announcements

Tissue Regenix Issues New Shares Post-Options Exercise

Tissue Regenix (GB:TRX) has released an update.

Don't Miss our Black Friday Offers:

Tissue Regenix Group PLC has announced the issuance of 821,167 new ordinary shares following the exercise of share options by senior employees, including the CEO and CFO, under the Company’s Long-Term Incentive Plan. The shares were sold to cover the costs associated with the options exercise, and the new shares are expected to begin trading on the AIM market. Post-admission, the total number of voting rights in Tissue Regenix will be 71,395,635 ordinary shares.

For further insights into GB:TRX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskTissue Regenix Celebrates Sustained Growth in H1 2024
TipRanks UK Auto-Generated NewsdeskTissue Regenix Announces Upcoming Interim Results
TipRanks UK Auto-Generated NewsdeskTissue Regenix Executives Receive Stock Options
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App